Expand DBVT Menu
DBVT MENU

DBVT Latest Press Releases

-- June 9, 2026 --

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference Globe Newswire 7:00 AM

-- June 8, 2026 --

DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 Globe Newswire 4:35 PM

-- June 5, 2026 --

DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference Globe Newswire 4:30 PM

-- June 3, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026 Globe Newswire 4:31 PM
DBV Technologies Announces the Results of its 2026 Combined General Meeting Globe Newswire 4:30 PM

-- June 2, 2026 --

DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy Globe Newswire 7:40 PM

-- May 13, 2026 --

Combined General Meeting of June 3, 2026 Globe Newswire 4:30 PM

-- May 12, 2026 --

DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq Globe Newswire 4:30 PM

-- April 30, 2026 --

DBV Technologies Reports First Quarter 2026 Financial Results Globe Newswire 4:30 PM

-- April 2, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 Globe Newswire 4:30 PM

-- March 26, 2026 --

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document Globe Newswire 5:19 PM
DBV Technologies Reports Full Year 2025 Financial Results and Business Update Globe Newswire 5:06 PM

-- March 24, 2026 --

DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Globe Newswire 4:30 PM

-- March 4, 2026 --

DBV Technologies to Participate in Upcoming March Investor Conferences Globe Newswire 4:30 PM

-- March 3, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 Globe Newswire 4:30 PM

-- February 28, 2026 --

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting Globe Newswire 2:25 PM

-- February 10, 2026 --

DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting Globe Newswire 4:30 PM

-- February 9, 2026 --

DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit Globe Newswire 4:30 PM

-- February 5, 2026 --

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026 Globe Newswire 4:30 PM

-- January 16, 2026 --

DBV Technologies Announces EUR 166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing Globe Newswire 6:11 PM
Market Data Delayed 15 Minutes